The Genomics Innovation Network (GIN)

The Genomics Innovation Network (GIN) is designed to enable innovation centres across Canada to collaborate and harness their collective power for the advancement of genomics research.

The network is comprised of 10 “Nodes,” each receiving core operational funding from Genome Canada, with matching funds from various public and private sector partners. The Nodes provide Canadian and international researchers access to leading-edge technologies used in genomics, metabolomics, proteomics and other related areas of research, and assist researchers in the development of research proposals by providing advice on appropriate technologies, study design, data analysis and bioinformatics that improve the quality of the research.

Furthermore, the highly-qualified personnel within each Node provide the Canadian research community with advice and expertise on the selection and use of appropriate technologies, study design, data analysis and bioinformatics, ensuring Canadian research remains world-class and highly competitive on a global scale.

Ontario Nodes

Five of the 10 nodes in Canada’s Genomics Innovation Network (GIN) were funded or co-funded in Ontario to advance genomics research. With over $6 million in funding from Genome Canada, these technology platforms (The Centre for Applied Genomics, Toronto Centre for Phenogenomics, the Network Biology Collaborative Centre in Ontario, and two centres in Quebec co-led by Ontario Genomics) provide researchers with access to cutting-edge genomics technologies.

Genomics Innovation Network Quick Facts

  • $15.5 million in Genome Canada federal funding is the initial investment made in core operations funding for the 10 Nodes, with each receiving between $800,000 and $2 million over two-years beginning April 1, 2015. Co-funding investments in the Nodes from other partners, including provincial governments, academic institutions, and the private sector at a required minimum 1:1 ratio bring the total initial investment in the Genomics Innovation Network to approximately $31 million.
  • A total of approximately ~$31 million was invested in the Genomics Innovation Network, with $15.5 million in federal funding through Genome Canada invested in the 10 Nodes’ core operations, and each Node receiving between $800,000 and $2 million over two-years beginning April 1, 2015. Co-funding investments in the Nodes represented the required minimum 1:1, and flowed from other partners such as provincial governments, academic institutions, and the private sector.
  • In addition, between 2015 and 2017 approximately $15 million will be invested in the Nodes towards technology development and collaborative projects. This further investment will also attract at least an equal amount in co-funding from partners in the public and private sector.
  • The Node selection was a competitive process involving peer review by an international review committee.
  • A new model, The Genomics Innovation Network replaces Genome Canada’s former investments in five Science and Technology Innovation Centres. The new Network model places greater emphasis on collaboration and sharing of expertise among Nodes.
  • Providing Canada’s research community with access to leading-edge technologies is a key pillar of Genome Canada’s mandate. The investment will also support important work in the area of bioinformatics and computational biology, including addressing major challenges associated with the storage and analysis of “big data,” and contribute to Canadian leadership in the development of new genomic technologies.
“Through our government’s low tax plan for jobs and growth, we have made record investments in Canadian science and technology including Genome Canada. Genome Canada’s new Genomics Innovation Network will provide leading Canadian researchers with new knowledge and new tools necessary to make breakthrough discoveries – discoveries that create jobs, prosperity and improve our quality of life as Canadians.”
 – The Honourable Ed Holder, Minister of State for Science and Technology 2014 - 2015
“Breakthroughs across all sectors that form part of Canada’s growing bioeconomy – health, agriculture, fisheries and aquaculture, forestry, energy and mining – rely on researchers across Canada having access to leading-edge ‘omics technologies, which are rapidly evolving. Moreover, we want to build on past successes where we’ve seen new genomics technology development become the foundation for Canadian business growth.”
 – Dr. Pierre Meulien, President and CEO, Genome Canada 2010 - 2015